SAB Biotherapeutics (SABS) Shareholding Patterns
$3.71
As on 04-Sep-2026 16:00EDT
Market cap
$338 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
15.5
P/B Ratio
1.6
Div. Yield
0 %
$3.71
As on 04-Sep-2026 16:00EDT
Market cap
$338 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
15.5
P/B Ratio
1.6
Div. Yield
0 %